Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengming Ou

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|July 28, 2025
Transforming the "cold" tumors to "hot" tumors: strategies for immune activationXueqing Kong, Shengming Ou, Zifei Wei, et al.
Oncogene|March 12, 2025
RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinomaJinrong Zhu, Lei Wang, Xiaoya Nie, et al.
Cell Death Discovery|January 18, 2025
Deciphering the mechanisms of long non-coding RNAs in ferroptosis: insights into its clinical significance in cancer progression and immunologyShengming Ou, Xiaoya Nie, Xiangyu Qiu, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 14, 2024
ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathwaysJinrong Zhu, Xiangyu Qiu, Xin Jin, et al.
Cell Death Discovery|January 24, 2024
Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammationXin Jin, Jiuren Tang, Xiangyu Qiu, et al.
Cancer Biology & Medicine|April 21, 2026
Unravelling the role of PANoptosis in diseases: from emerging molecular mechanisms-to-therapeutic implicationsYi Zhu, Shengming Ou, Xuer Ye, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|July 28, 2025
Transforming the "cold" tumors to "hot" tumors: strategies for immune activationXueqing Kong, Shengming Ou, Zifei Wei, et al.
Oncogene|March 12, 2025
RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinomaJinrong Zhu, Lei Wang, Xiaoya Nie, et al.
Cell Death Discovery|January 18, 2025
Deciphering the mechanisms of long non-coding RNAs in ferroptosis: insights into its clinical significance in cancer progression and immunologyShengming Ou, Xiaoya Nie, Xiangyu Qiu, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 14, 2024
ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathwaysJinrong Zhu, Xiangyu Qiu, Xin Jin, et al.
Cell Death Discovery|January 24, 2024
Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammationXin Jin, Jiuren Tang, Xiangyu Qiu, et al.
Cancer Biology & Medicine|April 21, 2026
Unravelling the role of PANoptosis in diseases: from emerging molecular mechanisms-to-therapeutic implicationsYi Zhu, Shengming Ou, Xuer Ye, et al.
Pageof 1